ATOS:US
$0.78
-0.763%

Atossa Therapeutics Inc.
News & Events

Last updated: Aug 14, 2025, 2:42 PM ET

  1. Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Update

    PR Newswire AUG 12, 2025 8:30 AM EDT
    Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Upda...
    READ ARTICLE
  2. Atossa Therapeutics Announces Positive FDA Feedback, Advances Toward IND for (Z)-Endoxifen Clinical Program in ER+/HER2- Metastatic Breast Cancer

    PR Newswire JUL 29, 2025 7:45 AM EDT
    Atossa Therapeutics Announces Positive FDA Feedback, Advances Toward IND for (Z)-Endoxifen Clinic...
    READ ARTICLE
  3. Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference

    PR Newswire JUN 2, 2025 8:45 AM EDT
    Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference PR Newswir...
    READ ARTICLE
  4. Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22

    ACCESS Newswire MAY 20, 2025 9:00 AM EDT
    SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS)...
    READ ARTICLE
  5. Atossa Therapeutics Announces Full Results from I?SPY?2 Endocrine?Optimization Sub?Study Evaluating Low?Dose (Z)?Endoxifen

    PR Newswire MAY 14, 2025 8:15 AM EDT
    Atossa Therapeutics Announces Full Results from I‑SPY 2 Endocrine‑Optimizati...
    READ ARTICLE
  6. Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Update

    PR Newswire MAY 13, 2025 8:00 AM EDT
    Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Updat...
    READ ARTICLE
  7. Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations for its (Z)-endoxifen Portfolio

    GlobeNewswire APR 30, 2025 8:45 AM EDT
    SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Ato...
    READ ARTICLE
  8. Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025

    GlobeNewswire APR 29, 2025 8:45 AM EDT
    SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Ato...
    READ ARTICLE
  9. Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio

    GlobeNewswire APR 22, 2025 8:45 AM EDT
    SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Ato...
    READ ARTICLE
  10. Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer

    PR Newswire APR 10, 2025 8:00 AM EDT
    Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies f...
    READ ARTICLE

Upcoming Events

Get notified of Atossa Therapeutics Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available